Clinical Trial Update: Evaluation of the Effect of Nigella Sativa for the Prophylaxis to Radiation Induced Dermatitis in Breast Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Nigella Sativa for prevention of radiation-induced dermatitis in breast cancer patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Radiation Dermatitis

Drugs mentioned

• Nigella Sativa (Nigella sativa)

Snippet

Sponsor: German University in Cairo | Conditions: Radiation Dermatitis | Phase 2 | Status: COMPLETED